Highlights and Quick Summary
- Additional Paid In Capital for the quarter ending December 31, 2022 was $169 Million (a -0.03% decrease compared to previous quarter)
- Year-over-year quarterly Additional Paid In Capital increased by 10.79%
- Annual Additional Paid In Capital for 2022 was $152 Million (a 0.57% increase from previous year)
- Annual Additional Paid In Capital for 2021 was $152 Million (a 17.66% increase from previous year)
- Annual Additional Paid In Capital for 2020 was $129 Million (a 1.18% increase from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Additional Paid In Capital of Benitec Biopharma Limited
Most recent Additional Paid In Capitalof BNTC including historical data for past 10 years.Interactive Chart of Additional Paid In Capital of Benitec Biopharma Limited
Benitec Biopharma Limited Additional Paid In Capital for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $168.72 | $168.77 | $152.45 | $152.29 | $152.45 |
| 2021 | $152.09 | $151.85 | $151.58 | $138.63 | $151.58 |
| 2020 | – | $138.4 | $128.85 | $128.83 | $128.83 |
| 2019 | – | – | – | – | $127.33 |
| 2016 | – | – | – | $0.0 | – |
| 2015 | – | – | – | $0.0 | – |
| 2014 | – | – | – | $0.0 | – |
| 2013 | $0.0 | – | – | – | – |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology